The Alcohol and Other Drugs Knowledge Centre is hosting a free webinar on Thursday 13 February 2020 with guest presenter Dr. Stephen Bright from the National Drug Research Institute at Curtin University and will follow with an open Q & A session. The webinar will run for approximately 40 minutes and is free to attend.
In 2011, synthetic cannabis products containing synthetic cannabinoid receptor agonists were being sold in Western Australia (WA) as “kronic”. Initial legislative responses led to increased harm due to the inadvertent promotion of products containing new synthetic cannabinoid receptor agonists that were more harmful than those first banned. After more than 40 state and federal legislative changes, overall rates of synthetic cannabis use in WA have fallen; though there is evidence to suggest the use of synthetic cannabis remains an issue among some marginalised populations and remote communities. This webinar will provide an overview of how synthetic cannabis emerged as a drug of concern in WA. In doing so, information will be provided to assist healthcare professionals to identify and respond to synthetic cannabis use.
There is no additional software required to join the webinar, other than a stable internet connection. We’d recommend that you use Google Chrome to view the webinar.
The webinar will be held at:
More information can be found here.
Access the webinar online here (please note the session will open approximately 10 minutes prior to the start time).
Participants are invited to register their interest prior to the event with the webinar organiser Vilma FitzGerald (contact details below).
Webinar Organiser
Vilma FitzGerald
Senior Research Officer
Australian Indigenous HealthInfoNet
Ph: (08) 6304 6328
Email: v.fitzGerald@ecu.edu.au
Please note that this webinar will be recorded, and will be made available on the HealthInfoNet website at a later date.
Insight (Qld) and 360Edge also offer AOD related trainings and workshops